117 related articles for article (PubMed ID: 2163737)
21. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J
Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330
[TBL] [Abstract][Full Text] [Related]
22. High affinity binding of VIP to human lung cancer cell lines.
Shaffer MM; Carney DN; Korman LY; Lebovic GS; Moody TW
Peptides; 1987; 8(6):1101-6. PubMed ID: 2831519
[TBL] [Abstract][Full Text] [Related]
23. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
[TBL] [Abstract][Full Text] [Related]
24. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
Van Valen F; Jürgens H; Winkelmann W; Keck E
Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the immunomodulatory properties of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells.
Nguyen TT; Krco CJ; Gores A; Go VL
Immunol Invest; 1987 Nov; 16(7):555-77. PubMed ID: 2832322
[TBL] [Abstract][Full Text] [Related]
26. Characterization of vasoactive intestinal peptide receptors in retina.
Swedlund AP; Rosenzweig SA
Exp Eye Res; 1990 Sep; 51(3):317-23. PubMed ID: 2169429
[TBL] [Abstract][Full Text] [Related]
27. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
[TBL] [Abstract][Full Text] [Related]
28. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium.
Elgavish A; Pillion DJ; Meezan E
Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697
[TBL] [Abstract][Full Text] [Related]
29. Vasoactive intestinal polypeptide receptors in rat cerebral vessels: an autoradiographic study.
Amenta F; Cavalotti C; De Michele M; De Vincentis G; Rossodivita A; Rossodivita I
J Auton Pharmacol; 1991 Oct; 11(5):285-93. PubMed ID: 1660895
[TBL] [Abstract][Full Text] [Related]
30. Epithelial cells purified from choroid plexus have receptors for vasoactive intestinal polypeptide.
Nilsson C; Fahrenkrug J; Lindvall-Axelsson M; Owman C
Brain Res; 1991 Mar; 542(2):241-7. PubMed ID: 1851455
[TBL] [Abstract][Full Text] [Related]
31. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line.
Nielsen FC; Gammeltoft S; Westermark B; Fahrenkrug J
Peptides; 1990; 11(6):1225-31. PubMed ID: 1965033
[TBL] [Abstract][Full Text] [Related]
32. The vasoactive intestinal peptide (VIP) receptor: recent data and hypothesis.
Luis J; Martin JM; el Battari A; Marvaldi J; Pichon J
Biochimie; 1988 Oct; 70(10):1311-22. PubMed ID: 2852963
[TBL] [Abstract][Full Text] [Related]
33. VIP regulation of a human pancreatic cancer cell line: Capan-1.
Ruellan C; Scemama JL; Clerc P; Fagot-Revurat P; Clemente F; Ribet A
Peptides; 1986; 7 Suppl 1():267-71. PubMed ID: 3018700
[TBL] [Abstract][Full Text] [Related]
34. The effects of ribavirin on the GTP level and the VIP receptor dynamic of human IGR39 cells.
Fouchier F; Forget P; Bellan C; Marvaldi J; Champion S; Pichon J
J Recept Signal Transduct Res; 1996; 16(1-2):39-58. PubMed ID: 8771530
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical localization of receptors for vasoactive intestinal peptide and substance P in human trachea.
Fischer A; Kummer W; Couraud JY; Adler D; Branscheid D; Heym C
Lab Invest; 1992 Sep; 67(3):387-93. PubMed ID: 1328764
[TBL] [Abstract][Full Text] [Related]
36. An endothelial cell-line contains functional vasoactive intestinal polypeptide receptors: they control inwardly rectifying K+ channels.
Pasyk E; Mao YK; Ahmad S; Shen SH; Daniel EE
Eur J Pharmacol; 1992 Mar; 212(2-3):209-14. PubMed ID: 1318211
[TBL] [Abstract][Full Text] [Related]
37. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors.
Luis J; Martin JM; el Battari A; Fantini J; Giannellini F; Marvaldi J; Pichon J
Eur J Biochem; 1987 Sep; 167(2):391-6. PubMed ID: 3040409
[TBL] [Abstract][Full Text] [Related]
38. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
Moody TW; Zia F; Draoui M; Brenneman DE; Fridkin M; Davidson A; Gozes I
Proc Natl Acad Sci U S A; 1993 May; 90(10):4345-9. PubMed ID: 8389448
[TBL] [Abstract][Full Text] [Related]
39. Direct demonstration of guanine nucleotide sensitive receptors for vasoactive intestinal peptide in the anterior lobe of the rat pituitary gland.
Agui T; Matsumoto K
Peptides; 1990; 11(3):609-11. PubMed ID: 2166281
[TBL] [Abstract][Full Text] [Related]
40. Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines.
Luis J; Said SI
Peptides; 1990; 11(6):1239-44. PubMed ID: 1965034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
